A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
Purpose
Category
Healthy Subjects Needed
Child Health
Wounds and Injuries
IRB Number
20200668HU
NCT Number
-
Sponsor
-
Study Contact
Principal Investigator
Michael Odom
Diana Anzueto Guerra
210-567-5225
anzuetod@uthscsa.edu